Comparison of Renal Function Indicators According to Hydration Volume in Patients Receiving Intravenous Acyclovir With CNS Infection

Abstract

Purpose:

We aimed to compare the changes in renal function indicators as a function of hydration volume in patients treated with acyclovir for suspected herpes simplex virus (HSV) infection.

Method:

We obtained data from 216 acyclovir-treated patients hospitalized between 2007 and 2012 for suspected HSV infection. Intravenous hydration volume and renal function indicators (serum creatinine [sCr], blood urea nitrogen [BUN], glutamate oxaloacetate transferase, glutamate pyruvate transferase, and uric acid levels; estimated glomerular filtration rate [eGFR]; and urine pH) were compared among the patients. The indicators were assessed before acyclovir infusion and after 3 days of acyclovir infusion.

Results:

Before acyclovir infusion, all the indicators were within normal ranges in all groups (hydration volume lower than 2 L/day, higher than 2 L/day, and without hydration). After acyclovir infusion for 3 days, the groups without hydration and with a volume lower than 2 L/day showed increased sCr (2.22 ± 0.51 and 1.70 ± 0.35 mg/dl, respectively), BUN levels (28.33 ± 0.57 and 22.14 ± 7.95 mg/dl, respectively), and glutamate oxaloacetate transferase (48.00 ± 2.65 IU/L, without hydration) and eGFRs lower than the normal range (53.03 ± 3.05 and 59.66 ± 10.25 ml/min, respectively; p < .001 for all parameters). The renal function indicators were within normal limits in the group with a hydration volume higher than 2 L/day.

Conclusions:

Renal function indicators in acyclovir-treated patients varied according to hydration volume. Health care providers should consider whether the hydration volume in each patient receiving intravenous acyclovir is sufficient for preventing nephropathy.

Keywords

CNS infection acyclovir renal function indicators

Get full access to this article

View all access options for this article.

References

Bai

S. J.

Lee

J. W.

Lee

K. Y.

(2010). Fluid therapy: Classification and characteristics of intravenous fluids. Journal of the Korean Medical Association, 53, 1103–1112.

Cho

J. H.

Jang

J. H.

Lee

D. H.

Lee

Y. K.

Noh

J. W.

Bae

J. H.

Kim

H. K.

(2010). Acyclovir-induced acute renal failure in a patient with suspected acute retinal necrosis syndrome. Journal of the Korean Ophthalmological Society, 51, 1528–1531.

Fleischer

Johnson

(2010). Acyclovir nephrotoxicity: A case report highlighting the importance of prevention, detection, and treatment of acyclovir-induced nephropathy. Case Reports in Medicine, 2010, 1–3.

Gunness

Aleksa

Bend

Koren

(2011). Acyclovir-induced nephrotoxicity: The role of the acyclovir aldehyde metabolite. Translational Research, 158, 290–301.

Izzedine

Launay-Vacher

Deray

(2005). Antiviral drug-induced nephrotoxicity. American Journal of Kidney Diseases, 45, 804–817.

Izzedine

Launay-Vacher

Isnard-Bagnis

Deray

(2003). Antiviral drug-induced kidney and electrolytes disorders. Minerva Urologica e Nefrologica, 55, 157–172.

S. Y.

Park

Y. B.

Lee

C. H.

(2011). The effect of hypouricemic treatment on the renal function in patients with gout. Journal of the Korean Rheumatism Association, 18, 26–31.

Kang

H. J.

Kim

C. D.

Tak

W. T.

Park

S. W.

Bae

H. S.

Park

S. H.

… Kim

Y. L.

(2006). Crystal-induced acute renal failure due to acyclovir in a renal transplant patient. Journal of the Korean Society of Transplantation, 20, 253–257.

Kim

H. S.

Kim

H. J.

Kang

J. Y.

Kim

E. J.

Park

K. W.

(2012). Herpes simplex encephalitis showing prominent spatial disorientation with visual hallucination. Journal of the Korean Neurological Association, 30, 120–124.

10.

Kim

J. S.

Yang

J. E.

Lee

B. Y.

Lee

S. H.

Park

H. J.

Lee

S. P.

Lee

S. K.

(2012). A case of neurotoxicity induced by valaciclovir in a continuous ambulatory peritoneal dialysis patient. Yeungnam University Journal of Medicine, 29, 121–124.

11.

Lee

J. W.

Kim

J. E.

Park

I. W.

Lim

S. G.

Song

K. E.

Cho

H. K.

… Kim

G. M.

(2004). Clinical science: A study on the appropriate normal range of serum creatinine level for Koreans. Korean Journal of Nephrology, 23, 721–728.

12.

Lee

S. H.

Jang

J. S.

Lee

S. Y.

Cho

Y. S.

Joo

H. J.

Kwon

S. K.

Kim

H. Y.

(2009). Two cases of acyclovir neurotoxicity in end stage of renal disease. Korean Journal of Nephrology, 28, 671–674.

13.

Meng

J. B.

Zheng

Zhang

Fang

(2011). Oral acyclovir induced acute renal failure. World Journal of Emergency Medicine, 2, 310–313.

14.

Munshi

Hsu

Himmelfarb

(2011). Advances in understanding ischemic acute kidney injury. BMC Medicine, 2, 9–11.

15.

Nash

Hafeez

Hou

(2002). Hospital-acquired renal insufficiency. American Journal of Kidney Diseases, 39, 930–936.

16.

Naughton

C. A.

(2008). Drug-induced nephrotoxicity. American Family Physician, 78, 743–750.

17.

Navaneethan

Lancaster

Venkatesh

P. G.

Wang

Neff

G. W.

(2011). Herpes simplex virus hepatitis—It’s high time we consider empiric treatment. Journal of Gastrointestinal and Liver Diseases, 20, 93–96.

18.

Obada

E. N.

Level

Mathieu

Parent

Gilson

Bindi

(2010). Acute renal failure following a treatment with acyclovir. Journal of Nephrology & Therapeutics, 6, 125–127.

19.

D. J.

(2012). Medical management of acute kidney injury, mainly focused on preventable diseases. Korean Journal of Medicine, 82, 11–16.

20.

Pacheco

L. R.

Tavares

H. M.

Moysés Neto

Dantas

Rocha

L. S.

Ribeiro

K. M.

Figueiredo

J. F.

(2005). Acute renal failure related to intravenous acyclovir. Revista da Associação Médica Brasileira, 51, 275–278.

21.

Paige

N. M.

Nagami

G. T.

(2009). The top 10 things nephrologists wish every primary care physician knew. Mayo Clinic Proceedings, 84, 180–186.

22.

Perazella

M. A.

(1999). Crystal-induced acute renal failure. American Journal of Medicine, 106, 459–465.

23.

Raschilas

Wolff

Delatour

Chaffaut

De Broucker

Chevret

… Rozenberg

(2002). Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: Results of a multicenter study. Clinical Infectious Diseases, 35, 254–260.

24.

Raymond

Michael

(2010). Acyclovir nephrotoxicity: A case report highlighting the importance of prevention, detection, and treatment of acyclovir-induced nephropathy. Case Reports in Medicine, 2010, 1–3.

25.

Roos

K. L.

(2006). Viral meningitis and encephalitis. In Noseworthy

J. H.

(Ed.), Neurological therapeutics: Principles and practice (2nd ed., pp. 990–1010). London, England: Informa Healthcare.

26.

Rozenberg

Deback

Agut

(2011). Herpes simplex encephalitis: From virus to therapy. Infectious Disorders—Drug Targets, 11, 235–250.

27.

Scheld

W. M.

Whitley

R. J.

Marra

C. M.

(2004). Infections of the central nervous system (3rd ed.). Philadelphia, PA: Lippincott Williams & Wilkins.

28.

Schetz

Dasta

Goldstein

Golper

(2005). Drug-induced acute kidney injury. Current Opinion in Critical Care, 11, 555–565.

29.

Smith

J. P.

Weller

Johnson

Nicotera

Luther

J. M.

Haas

D. W.

(2010). Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function. Antimicrobial Agents and Chemotherapy, 54, 1146–1151.

30.

Sodhi

P. K.

Ratan

S. K.

(2003). A case of chronic renal dysfunction following treatment with oral acyclovir. Scandinavian Journal of Infectious Diseases, 35, 770–772.

31.

Stevens

L. A.

Coresh

Greene

Levey

A. S.

(2006). Assessing kidney function—Measured and estimated glomerular filtration rate. New England Journal of Medicine, 354, 2473–2483.

32.

Tyler

K. L.

(2004). Herpes simplex virus infections of the central nervous system: Encephalitis and meningitis, including Mollaret’s. Herpes. The Journal of the IHMF, 11, 57–64.